Your browser doesn't support javascript.
loading
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response.
Sidiqi, M Hasib; Aljama, Mohammed A; Jevremovic, Dragan; Morice, William G; Timm, Michael; Buadi, Francis K; Warsame, Rahma; Lacy, Martha Q; Dispenzieri, Angela; Dingli, David; Gonsalves, Wilson I; Kumar, Shaji; Kapoor, Prashant; Kourelis, Taxiarchis; Leung, Nelson; Hogan, William J; Muchtar, Eli; Lust, John A; Rajkumar, Vincent S; Gertz, Morie A.
Afiliação
  • Sidiqi MH; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Aljama MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Jevremovic D; Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, USA.
  • Morice WG; Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, USA.
  • Timm M; Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, USA.
  • Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Warsame R; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Dingli D; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Gonsalves WI; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Kumar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Kourelis T; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Leung N; Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, USA.
  • Hogan WJ; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Muchtar E; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Lust JA; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Rajkumar VS; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA.
  • Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, USA. gertz.morie@mayo.edu.
Bone Marrow Transplant ; 54(3): 442-447, 2019 03.
Article em En | MEDLINE | ID: mdl-30087461
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmócitos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmócitos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido